Plasmin degradation of the alpha chain of fibrinogen/fibrin: improved activation constant and activity determination in assays for tissue plasminogen activator

被引:0
作者
Garces, Tatiana M. P. [1 ]
Alfonso Quijano, P. [1 ]
Luis Fernando Arbelaez, R. [1 ]
机构
[1] Univ Pamplona, Hlth Fac, Chem Res Grp, Km 1 Via Bucaramanga,Ciudadela Univ Pamplona, Pamplona, Colombia
关键词
Fibrin; Fibrinogen; Plasmin; Plasminogen; Tissue Plasminogen Activator;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. The aim of this investigation was to increase the efficiency of ternary complex formation (fibrin-plasminogen-tissue-plasminogen activator) in the degradation process of the three-dimensional soluble fibrin monomer. Materials and methods. Fibrinogen was purified from human plasma by repeating precipitation six times, using different concentrations of cold ethanol. Fibrinogen was converted to DesAAfibrinogen by degradation with bathroxobin. Human plasminogen was purified by affinity and ion-exchange chromatography, and activated to plasmin by incubation with urokinase. Digested DesAAfibrinogen was prepared by controlled digestion with plasmin. Results. This study demonstrates that the alpha-chains of DesAAfibrinogen sterically hinder the formation of the ternary complex and are first degraded by plasmin. The degradation of fibrin(ogen) facilitates the in vitro determination of tissue plasminogen activator activity. Finally, release of fibrinopeptide A from bathroxobin-cleaved fibrinogen was confirmed, optimized and evaluated by various methods. Conclusions. Use of digested desAAfibrinogen with plasmin yielded a more stable activation constant of the ternary complex than that of undigested DesAAfibrinogen.
引用
收藏
页码:291 / 301
页数:11
相关论文
共 43 条
[1]   The Argatroban and Tissue-Type Plasminogen Activator Stroke Study Final Results of a Pilot Safety Study [J].
Barreto, Andrew D. ;
Alexandrov, Andrei V. ;
Lyden, Pat ;
Lee, Jessica ;
Martin-Schild, Sheryl ;
Shen, Loren ;
Wu, Tzu-Ching ;
Sisson, April ;
Pandurengan, Renganayaki ;
Chen, Zhongxue ;
Rahbar, Mohammad H. ;
Balucani, Clotilde ;
Barlinn, Kristian ;
Sugg, Rebecca M. ;
Garami, Zsolt ;
Tsivgoulis, Georgios ;
Gonzales, Nicole R. ;
Savitz, Sean I. ;
Mikulik, Robert ;
Demchuk, Andrew M. ;
Grotta, James C. .
STROKE, 2012, 43 (03) :770-775
[2]  
BERGMANN SR, 1983, SCIENCE, V220, P1181
[3]   UROKINASE-TYPE PLASMINOGEN-ACTIVATOR - PROENZYME, RECEPTOR, AND INHIBITORS [J].
BLASI, F ;
VASSALLI, JD ;
DANO, K .
JOURNAL OF CELL BIOLOGY, 1987, 104 (04) :801-804
[4]  
BLOMBACK B, 1957, ARK KEMI, V10, P415
[5]  
Canas O, 2007, REV BISTUA, P43
[6]  
CHMIELEWSKA J, 1986, CLIN CHEM, V32, P482
[7]   EVIDENCE FOR A RAPID INHIBITOR TO TISSUE PLASMINOGEN-ACTIVATOR IN PLASMA [J].
CHMIELEWSKA, J ;
RANBY, M ;
WIMAN, B .
THROMBOSIS RESEARCH, 1983, 31 (03) :427-436
[8]   Factors and Outcomes Associated with Recanalization Timing after Thrombolysis [J].
Cho, Kyung-Hee ;
Lee, Deok Hee ;
Kwon, Sun U. ;
Choi, Choong Gon ;
Kim, Sang Joon ;
Suh, Dae-Chul ;
Kim, Jong S. ;
Kang, Dong-Wha .
CEREBROVASCULAR DISEASES, 2012, 33 (03) :255-261
[9]   PLASMINOGEN ACTIVATORS, TISSUE DEGRADATION, AND CANCER [J].
DANO, K ;
ANDREASEN, PA ;
GRONDAHLHANSEN, J ;
KRISTENSEN, P ;
NIELSEN, LS ;
SKRIVER, L .
ADVANCES IN CANCER RESEARCH, 1985, 44 :139-266
[10]   PLASMINOGEN - PURIFICATION FROM HUMAN PLASMA BY AFFINITY CHROMATOGRAPHY [J].
DEUTSCH, DG ;
MERTZ, ET .
SCIENCE, 1970, 170 (3962) :1095-+